BPC-157 vs LL-37
A side-by-side look at two popular peptides and how they compare.
Overview
BPC-157 and LL-37 are both peptides with protective properties but serve very different biological functions. BPC-157 is a gastric peptide associated with tissue repair and recovery across multiple organ systems, while LL-37 is a human cathelicidin antimicrobial peptide that provides direct defense against pathogens. Comparing them reveals the distinction between regenerative and defensive peptide strategies. Their unique profiles make them complementary rather than competitive options.
BPC-157
BPC-157 is a 15-amino-acid gastric peptide with extensive preclinical data supporting its associations with tissue protection and recovery. It influences growth factor expression, nitric oxide signaling, and angiogenesis across gut, musculoskeletal, and other tissue types. BPC-157 is commonly sought for its versatile regenerative and protective properties.
LL-37
LL-37 is the only cathelicidin-derived antimicrobial peptide in humans, providing frontline innate immune defense. It physically disrupts pathogen cell membranes, recruits immune cells, and modulates inflammatory responses. LL-37 is commonly sought for antimicrobial support, immune defense, and biofilm disruption.
Side-by-Side Comparison
| Category | BPC-157 | LL-37 |
|---|---|---|
| Primary Focus | Tissue protection and multi-system recovery | Antimicrobial defense and innate immune support |
| How It Works | Growth factors, NO pathways, angiogenesis | Membrane disruption of pathogens, immune cell recruitment |
| Antimicrobial Activity | Not a primary antimicrobial agent | Directly kills bacteria, viruses, and fungi |
| Tissue Repair | Strong associations with tissue recovery and protection | Some wound healing support, but secondary to antimicrobial role |
| Who It's For | Those focused on tissue recovery and gut protection | Those focused on immune defense and pathogen resistance |
| Administration | Subcutaneous injection or oral in research settings | Subcutaneous injection in research settings |
Key Differences
BPC-157 is fundamentally a repair and protection peptide with no direct antimicrobial activity, while LL-37 is fundamentally an antimicrobial peptide with tissue repair as a secondary function. Their applications are distinct: BPC-157 for recovery from tissue damage, LL-37 for defense against pathogens. LL-37's unique ability to disrupt biofilms sets it apart from most peptides.
Key Similarities
Both peptides contribute to the body's defense systems in their own ways: BPC-157 through tissue resilience and LL-37 through pathogen defense. They each have anti-inflammatory properties and support wound healing processes. Both are naturally derived from endogenous human proteins.
Which One Might Be Right for You?
BPC-157 is the better choice for those primarily interested in tissue recovery, gut protection, and musculoskeletal wellness. LL-37 is more appropriate for those focused on antimicrobial defense, immune support, or situations where pathogen resistance is a priority. For comprehensive body defense combining both recovery and immune protection, some protocols explore using both peptides. Individual wellness priorities and provider assessment should guide selection.
BPC-157 vs LL-37 FAQ
For Patients
Looking for peptide therapy? Get matched with a qualified provider near you.
Related Pages
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Peptide therapies should only be administered by licensed healthcare providers. Always consult with a qualified healthcare professional before starting any new treatment. PeptideLeads is a marketing agency and does not provide medical services.